• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬化性腺病作为乳腺癌双侧性和多中心性的预测指标。

Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity.

作者信息

Oiwa Mikinao, Endo Tokiko, Ichihara Shu, Moritani Suzuko, Hasegawa Masaki, Iwakoshi Akari, Sato Yasuyuki, Morita Takako, Hayashi Takako, Kato Aya

机构信息

Department of Radiology, Nagoya Medical Center, 4-1-1 Sannnomaru, Naka-ku, Nagoya, 460-0001, Japan,

出版信息

Virchows Arch. 2015 Jul;467(1):71-8. doi: 10.1007/s00428-015-1769-9. Epub 2015 Apr 3.

DOI:10.1007/s00428-015-1769-9
PMID:25838080
Abstract

Breast cancer is occasionally complicated by sclerosing adenosis (SA). Although both lesions usually originate in the terminal duct lobular unit, their pathogenetic relationship has not yet been elucidated. The present study analyzed 63 breast cancer patients with SA (involving a total of 75 breasts) to clarify if coexisting SA increased the frequency of multicentric breast cancer or not. Using the topographical classification proposed in our previous study, breast cancers with SA were classified into the following three types: type A (n = 22), cancer area was completely surrounded by the SA; type B (n = 26), cancer area partially overlapped the SA; and type C (n = 27), cancer area was located separate from the SA. Breast cancers with SA had a significant (P < 0.001) increase in frequency of harboring bilateral and multicentric cancers [17 of 63 (27%) and 15 of 63 (24%), respectively] when compared to breast cancer patients without SA, regardless of topographical type. Breast cancers with SA were less invasive (P < 0.001), of lower histological grade (P = 0.034), and had similar frequency of estrogen receptor-positive (P = 0.21) and HER2-positive (P = 0.74) tumors. In conclusion, contralateral and ipsilateral multicentric breast cancers occurred at a higher frequency in those with SA. Our data suggest that SA is, in addition to lobular neoplasia, a predictor of multicentric breast cancers.

摘要

乳腺癌偶尔会并发硬化性腺病(SA)。尽管这两种病变通常都起源于终末导管小叶单位,但其发病机制尚未阐明。本研究分析了63例患有SA的乳腺癌患者(共涉及75个乳房),以明确共存的SA是否会增加多中心性乳腺癌的发生率。采用我们先前研究中提出的地形学分类方法,将伴有SA的乳腺癌分为以下三种类型:A型(n = 22),癌灶完全被SA包围;B型(n = 26),癌灶部分与SA重叠;C型(n = 27),癌灶与SA分开。与无SA的乳腺癌患者相比,伴有SA的乳腺癌无论地形学类型如何,双侧和多中心癌的发生率均显著增加(P < 0.001)[分别为63例中的17例(27%)和63例中的15例(24%)]。伴有SA的乳腺癌侵袭性较小(P < 0.001),组织学分级较低(P = 0.034),雌激素受体阳性(P = 0.21)和HER2阳性(P = 0.74)肿瘤的发生率相似。总之,SA患者对侧和同侧多中心乳腺癌的发生率更高。我们的数据表明,除小叶肿瘤外,SA也是多中心乳腺癌的一个预测指标。

相似文献

1
Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity.硬化性腺病作为乳腺癌双侧性和多中心性的预测指标。
Virchows Arch. 2015 Jul;467(1):71-8. doi: 10.1007/s00428-015-1769-9. Epub 2015 Apr 3.
2
Topographical, morphological and immunohistochemical characteristics of carcinoma in situ of the breast involving sclerosing adenosis. Two distinct topographical patterns and histological types of carcinoma in situ.乳腺硬化性腺病伴原位癌的组织形态学及免疫组化特征。两种不同部位形态学类型及原位癌组织学类型的乳腺硬化性腺病伴原位癌。
Histopathology. 2011 May;58(6):835-46. doi: 10.1111/j.1365-2559.2011.03792.x. Epub 2011 Mar 14.
3
Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence.伴有硬化性腺病的导管原位癌:双侧乳腺癌的高发生率。
Clin Breast Cancer. 2012 Dec;12(6):398-403. doi: 10.1016/j.clbc.2012.08.002. Epub 2012 Oct 17.
4
A clinico-pathological study on cancer in sclerosing adenosis.
Breast Cancer. 2014 Nov;21(6):732-7. doi: 10.1007/s12282-013-0450-x. Epub 2013 Feb 14.
5
Multicentricity and bilaterality in invasive breast carcinoma.浸润性乳腺癌的多中心性和双侧性
Surgery. 1982 Feb;91(2):234-40.
6
Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case-control study from the Mayo Benign Breast Disease Cohort.硬化性腺病及相邻正常乳腺终末导管小叶单位中的Ki-67表达:来自梅奥良性乳腺疾病队列的巢式病例对照研究
Breast Cancer Res Treat. 2015 May;151(1):89-97. doi: 10.1007/s10549-015-3370-y. Epub 2015 Apr 12.
7
Role of contralateral breast biopsy in infiltrating lobular cancer.
Surgery. 1993 Sep;114(3):555-7.
8
Clinicopathologic analysis of breast lesions associated with multiple papillomas.与多发性乳头状瘤相关的乳腺病变的临床病理分析
Hum Pathol. 2003 Mar;34(3):234-9. doi: 10.1053/hupa.2003.25.
9
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer.
Cancer. 1975 Jan;35(1):247-54. doi: 10.1002/1097-0142(197501)35:1<247::aid-cncr2820350130>3.0.co;2-s.
10
The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.多灶/多中心肿瘤对乳腺癌患者无病生存的重要性:单中心经验。
Am J Clin Oncol. 2012 Dec;35(6):580-6. doi: 10.1097/COC.0b013e31822d9cd6.

引用本文的文献

1
Developing ultrasound-based machine learning models for accurate differentiation between sclerosing adenosis and invasive ductal carcinoma.开发基于超声的机器学习模型,用于准确区分硬化性腺病和浸润性导管癌。
Eur Radiol. 2025 Jun 28. doi: 10.1007/s00330-025-11777-w.
2
Beyond BI-RADS: Nonmass Abnormalities on Breast Ultrasound.超越 BI-RADS:乳腺超声的非肿块性异常。
Korean J Radiol. 2024 Feb;25(2):134-145. doi: 10.3348/kjr.2023.0769. Epub 2024 Jan 10.
3
Breast Sclerosing Adenosis and Accompanying Malignancies: A Clinicopathological and Imaging Study in a Chinese Population.

本文引用的文献

1
Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.根据 HER2 扩增状态和分子亚型对乳腺导管原位癌 (DCIS) 的组织病理学特征进行描述。
Virchows Arch. 2014 Sep;465(3):275-89. doi: 10.1007/s00428-014-1609-3. Epub 2014 Jun 29.
2
A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors.早期同步双侧乳腺癌的临床病理研究:潜在风险因素的回顾性评估与前瞻性验证
PLoS One. 2014 Apr 15;9(4):e95185. doi: 10.1371/journal.pone.0095185. eCollection 2014.
3
乳腺硬化性腺病及伴发恶性肿瘤:一项中国人群的临床病理与影像学研究
Medicine (Baltimore). 2015 Dec;94(49):e2298. doi: 10.1097/MD.0000000000002298.
Sclerosing adenosis and risk of breast cancer.
硬化性腺病与乳腺癌风险。
Breast Cancer Res Treat. 2014 Feb;144(1):205-12. doi: 10.1007/s10549-014-2862-5. Epub 2014 Feb 8.
4
A clinico-pathological study on cancer in sclerosing adenosis.
Breast Cancer. 2014 Nov;21(6):732-7. doi: 10.1007/s12282-013-0450-x. Epub 2013 Feb 14.
5
Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence.伴有硬化性腺病的导管原位癌:双侧乳腺癌的高发生率。
Clin Breast Cancer. 2012 Dec;12(6):398-403. doi: 10.1016/j.clbc.2012.08.002. Epub 2012 Oct 17.
6
A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes.一项单侧与同期双侧乳腺癌结局比较的病例对照研究。
J Clin Oncol. 2011 Dec 20;29(36):4763-8. doi: 10.1200/JCO.2011.35.0165. Epub 2011 Nov 21.
7
Topographical, morphological and immunohistochemical characteristics of carcinoma in situ of the breast involving sclerosing adenosis. Two distinct topographical patterns and histological types of carcinoma in situ.乳腺硬化性腺病伴原位癌的组织形态学及免疫组化特征。两种不同部位形态学类型及原位癌组织学类型的乳腺硬化性腺病伴原位癌。
Histopathology. 2011 May;58(6):835-46. doi: 10.1111/j.1365-2559.2011.03792.x. Epub 2011 Mar 14.
8
Sclerosing adenosis of the breast: radiologic appearance and efficiency of core needle biopsy.乳腺硬化性腺病:影像学表现及核心针活检的效能。
Diagn Interv Radiol. 2011 Dec;17(4):311-6. doi: 10.4261/1305-3825.DIR.3785-10.2. Epub 2011 Feb 15.
9
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.美国临床肿瘤学会/美国病理学家学会关于乳腺癌雌激素和孕激素受体免疫组织化学检测的指南建议。
J Clin Oncol. 2010 Jun 1;28(16):2784-95. doi: 10.1200/JCO.2009.25.6529. Epub 2010 Apr 19.
10
NUCKS overexpression in breast cancer.NUCKS在乳腺癌中的过表达。
Cancer Cell Int. 2009 Aug 10;9:19. doi: 10.1186/1475-2867-9-19.